Curriculum vitae

Tauber Eye Center
4400 Broadway, Suite 202
Kansas City, MO 64111
(816) 531-9100
(816) 531-9105 FAX
Education

Bachelor of Sciences in Biology and Chemistry Doctor of Medicine Harvard Medical School
Postdoctoral Training

7/82-6/83
7/83-6/84
7/84-6/87
7/87-6/88
7/88-6/89
Fellowship in Corneal and External Diseases
Licensure and Certification

Diplomate National Board of Medical Examiners Diplomate of the American Board of Ophthalmology Academic Appointments
1999-2011

1999-Present

1998-1999
Clinical Professor of Ophthalmology University of Missouri-Kansas City School of Medicine 1994-1997
Clinical Associate Professor of Ophthalmology University of Missouri-Kansas City School of Medicine 1989-1993
Clinical Assistant Professor of Ophthalmology University of Missouri-Kansas City School of Medicine 1991-1999
Director of Clinical Research University of Missouri-Kansas City School of Medicine Hospital Staff Appointments

1989-Present
1989-Present
St. Lukes Hospital of Kansas City-Kansas City, MO 1997-Present
Menorah Medical Center-Overland Park, KS
Honors, Awards and Distinctions
Union College

Harvard
Medical School

Northwestern
Medical Center

Tufts-New England
Medical Center
Charles J. Preefer Resident Research Award
Massachusetts
National Eye Institute Individual NRSA Award Eye & Ear
Infirmary

Heed Ophthalmic Foundation Fellowship 1987-88 Heed Foundation/Knapp Fellowship 1988-89
Post - Training
American Academy of Ophthalmology Achievement Award, 2005 American Academy of Ophthalmology Program Committee Member, Cornea Subcommittee 2002 - 2006
Professional Affiliations

Association for Research in Vision and Ophthalmology Metropolitan Medical Society of Greater Kansas City Kansas City Society of Ophthalmology & Otolaryngology Bibliography
Versatile Method for Evaluating a Cell Culture by Various Morphological Techniques.
Stain Technology 57: 331-347, 1982 Cryotherapy for Iris Neovascularization and Neovascular glaucoma. Ocular Circulation and Neovascularization ed. By D BenEzra, SJ Ryan, BM Glaser And RP Murphy, Documenta Ophthalmologica Proceedings, Series 50, pp. 383-386, Martinus Nijhoff/DR W Junk Publishers, 1987 New Clinical Classification for Iris Neovascularization. Ophthalmology 94 (5): 542-544, 1987 Simplified Diagnostic Coding Sheet for Computerized Data Storage and Analysis in Ophthalmology Ophthalmic Surgery 18 (11) : 846-849, 1987. Dramatic Improvement Following Plasmapheresis in the Atopic Keratoconjunctivitis Associated with Hyper IgE Ophthalmology 95 (4): 444-447, 1988. Cataract Surgery in Ocular Cicatricial Pemphigoid. Sainz de la Maza M, Tauber J, Foster CS. Ophthalmology 95 (4): 481-486, 1988. Lymphocyte Proliferation After HSV-1 Infection in Igh-1 Disparate Congenic Murine Strains. Investigative Ophthalmology Visual Science 29 (Suppl): 152, 1988. Scleral Grafting in Necrotizing Scleritis. Sainz de la Maza M, Tauber J, Foster CS. Ophthalmology 95 (9) Suppl: 161, 1988. Glaucoma in Patients with Ocular Cicatricial Pemphigoid. Ophthalmology 96 (1): 33-37, 1989 Systemic Immunologic Responses Following Intracameral Inoculation of HSV-1 in Susceptible and Resistant Igh-1 Disparate Congenic Murine Strains. Tauber J, Hemady R, Ihley T, Opremcak EM, Foster CS. Investigative Ophthalmology Visual Science 30 (Suppl): 359, 1989. Value of Conjunctival Biopsy in Peripheral Ulcerative Keratitis. Sainz de la Maza M, Foster CS, Tauber J, Hoang-Xuan T. Ophthalmology 96 (9) Suppl: 121, 1989. An Analysis of Therapeutic Decision Making in Peripheral Ulcerative Keratitis. Tauber J, Hoang-Xuan T, Sainz de la Maza M, Foster CS. Viral Isolation and Systemic Immune Responses After Intracameral Inoculation of Herpes Simplex Virus type 1 in Igh-1 Disparate Congenic Murine Strains. Hemady R, Tauber J, Ihley TM, Opremcak EM, Foster CS. Investigative Ophthalmology Visual Science 31 (11): 2335-2341, 1990. Ocular Cicatricial Pemphigoid (OCP) – The Potential for Cure. Ophthalmology 97 (9) Suppl: 132, 1990. Bibliography
Systemic Chemotherapy for Ocular Cicatricial Pemphigoid.
Tauber J, Sainz de la Maza M, Foster CS. Romberg’s Progressive Hemifacial Atrophy: An Association with Spontaneous Scleral Melting. Hoang-Xuan T, Foster CS, Jakobiec FA, Tauber J, Sainz de la Maza M, Krebs W. Immunomodulators in Immune and Inflammatory Diseases of the Eye. Survey of Ophthalmology 35 (5): 369-385, 1991. Investigation and Treatment of Peripheral Corneal Ulcers. Foster CS, Tauber J, Sainz de la Maza M, Hoang-Xuan T. In 4th Worksop on External Eye Disease & Inflammation, Medical Communications Services Limited, Oxted, Surrey. pp. 13-21, 1990. Remission and Recurrence after Withdrawal of Therapy for Ocular Cicatricial Pemphigoid. Archives of Ophthalmology 110: 1171, 1992. Improved Detection of Disease Progression in Ocular Cicatricial Pemphigoid. The Effectiveness of Excimer Photorefractive Keratectomy for Myopia. Piebenga LW, Deitz MR, Irvine JW, Matta CS, Tauber J, Sabates FN. Ophthalmology 99 (9A): 106, 1992. Long Term Results of Systemic Chemotherapy for Ocular Cicatricial Pemphigoid. Doc Ophthalmology 82 (3): 223-229, 1992. Kayser-Fleisher Ring of the Cornea Associated with Non-Wilsonian Liver Disease. Improvement in Squamous Metaplasia Following AquasiteTM Treatment in Patients with Dry Eye Syndrome and in Normal Volunteers. Investigative Ophthalmology Visual Science 34 (4): 2693, 1993. Regional Impression Cytology Abnormalities in Normal Volunteers. Rupani M, Crosser VA, Tauber J, Mardelli PM. Investigative Ophthalmology Visual Science 34 (4): 2693, 1993. Corneal Topographic Abnormalities Following the Use of Artificial Lubricants. Investigative Ophthalmology Visual Science 34 (4): 3809, 1993. Comparison of Expanding versus Contracting Diaphragm Movement in Excimer Laser Photoablation Without Nitrogen Gas Flow. Drew S, Walline TA, Tauber J, Cobb CJ, Gardner L. Investigative Ophthalmology Visual Science 34 (4): 490, 1993. Improvement in Squamous Metaplasia and Tear Osmolarity Following AquasiteTM Treatment. Ophthalmology 100 (9A): 108, 1993. Bibliography
Retreatment of PRK Refractive Failures
Matta CS, Piebenga LW, Deitz MR, Tauber J. Ophthalmology 100 (9A): 108, 1993. A Retrospective Review Comparing Iris-Fixated Vs. Open Loop ACIOLs with Penetrating Keratoplasty. Tauber J, Bealer L, Cavanaugh T, Durrie D. Journal Of Cataract And Refractive Surgery (Suppl): 71, 1993. Excimer Photorefractive Keratectomy for Myopia. Piebenga LW, Deitz MR, Matta CS, Tauber J, Irvine JW, Sabates FN. Ophthalmology 100 (9): 1335-1345, 1993. Piebenga LW, Matta CS, Deitz MR, Tauber J. Ophthalmology 100 (9A): 108, 1993. A Multicenter Comparison of Diclofenac Sodium 0.1% (DS) to Ketorolac Tromethamine 0.5% (KT) in Patients with Acute Seasonal Allergic Conjunctivitis (SAC). Investigative Ophthalmology Visual Science 35 (4): 1291, 1994. Changes in Corneal Topography After Instillation of Artificial Lubricants. Investigative Ophthalmology Visual Science 35 (4): 1291, 1994. Contact Lens and Spectacle Use Before and After PRK. In: Mannis MJ, Macsai MS, Huntley AC, Eds. Diseases of the Eye and Skin, New York, Raven In: Mannis MJ, Macsai MS, Huntley AC, eds. Diseases of the Eye and Skin, New York, Raven In: Krachmer JH, Mannis MJ, Holland EJ, Eds. Cornea, St. Louis, CV Mosby, 1996. Two Zone Excimer Photorefractive Keratectomy for Moderate Myopia. 6 to 18 Month Followup. Piebenga LW, Matta CS, Deitz MR, Tauber J. Ophthalmology 102: 1054-1059, 1995. Duration of Tear Osmolarity Changes Following Instillation of Artificial Lubricants In Patients Investigative Ophthalmology and Visual Science 36: S998, 1995. The Effects of Instillation of Topical NSAIDs on Corneal Sensation. Tauber J, Garner L, Niknia H, Crosser V. Investigative Ophthalmology and Visual Science 36: S576, 1995. Temporary Intracanalicular Collagen Implants In Normal Volunteers. Investigative Ophthalmology and Visual Science 37: S853, 1996. Epidemiological Study of Punctal Size in Normal Volunteers. Investigative Ophthalmology and Visual Science 37: S566, 1996. Bibliography
Photorefractive Keratectomy Results as a function of Preoperative Astigmatism.
Investigative Ophthalmology and Visual Science 37: S566, 1996. Five and Three Year Follow-up of Photorefractive Keratectomy for Myopia of –1 to –6 Diopters. Matta CS, Piebenga LW, Deitz MR, Tauber J, Garner L. Journal of Refractive Surgery 14:318-324, 1998 Excimer Retreatment for Myopic Photorefractive Keratectomy Failures. Six to 18 Month Follow-up. Matta CS, Piebenga LW, Deitz MR, Tauber J. Ablation Zone Centration after Photorefractiuve Keratectomy and Its Effect on Visual Outcome. Deitz MR, Piebenga LW, Matta CS, Tauber J, Anello RD, DeLuca M Journal of Cataract and Refractive Surgery 22(6): 696-701, 1996 The Effects of Instillation of Diclofenac sodium 0.1% on Photophobia following Pupillary Dilation. Investigative Ophthalmology Visual Science 38 (4): S142, 1997 A Multicenter Comparison of the Ocular Efficacy and Safety of Diclofenac 0.1% Solution with that Of Ketoralac Tromethamine 0.5% Solution in Patients with Acute Seasonal Allergic Conjunctivitis. Tauber J, Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Journal of Ocular Pharmacology and Therapeutics 14 (2): 137-146, 1998 Evaluation of Two Different Methods of Epithelial Removal Prior to Excimer Laser Tauber J, Cable M, Chavala S, Polepalle S. Investigative Ophthalmology Visual Science 40 (4): S107, 1999 Refractive Outcomes Following Excimer Laser Photorefractive Keratectomy for Myopia Using Cable M, Matta C, Piebenga L, Polepalle S, Steward C, Tauber J. Investigative Ophthalmology Visual Science 40 (4): S106, 1999 Safety and Efficacy of Nedocromil Sodium Ophthalmic Solution 25 BID in Patients with Ocular Itch Associated Tauber J, Alocril Community Ocular Allergy Trial Study Group Investigative Ophthalmology Visual Science 42(4) S910, March 2001 Efficacy and Safety of Combination Therapy with Brimonidine 0.2% and Latanoprost 0.005% Versus Fixed Zabriskie N A, Ahmed I K, Cantor L B, Kent A B, Mundorf T, Tauber J, Rubin J M, Hoop J Investigative Ophthalmology Visual Science 42 (4) S833, March 2001 Phase 2 Dose Ranging Efficacy Trial of INS365 Ophthalmic Solution, A P2Y2 Agonist, in Patients with Dry Eye. Foulks G, Sall K, Greenberg M, Tauber J, Donshik P, Berdy G, Sylvester R, Yerxa B, Crockett S, Investigative Ophthalmology Visual Science 42 (4) S713, March 2001 Nedocromil Sodium Ophthalmic Solution 2% Twice Daily in Patients with Allergic Conjunctivitis. Tauber J, and the Alocril Community Allergy Trial Study Group Advances in Therapy 19 (2) 73-84, March / April 2002 Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafasol Tetrasodium (INS365) Ophthalmic Bibliography

Parasitic Keratitis and Conjunctivitis.
In: Foster CS, Azar DT, Dohlman CH, Eds. The Cornea, 4th Edition, Philadelphia, Lippincott Williams & In: Krachmer JH, Mannis MJ, Holland EJ, Eds. Cornea, 2nd ed., St. Louis, CV Mosby, 2004. Phase III Safety Evaluation of Cyclosporine 0.1% Ophthalmic Emulsion Administered Twice Daily to Dry Eye Barber LD, Pflugfelder SC, Tauber J, Foulks GN Ophthalmology 112: 1790-1794, 2005. Contemporary Ophthalmology in press, 2006. Efficacy, Tolerability And Comfort Of A 0.3% Hypromellose Gel Ophthalmic Lubricant In The Treatment Of Patients With Moderate To Severe Dry Eye Syndrome. Current Medical Research and Opinions 23: 2629-2636, 2007. Tauber J In: Price, Ed. Curbside Consultation in Cornea and External Disease. Thoroughfare NJ, Slack, 2010 in Intraocular Inflammation, ed. Zierhut, M, Ohno S, Orefice F, Pavesio C, Rao N. (Eds.) Springer Verlag, Heidelberg, Germany, 2011. in Intraocular Inflammation, ed. Zierhut, M, Ohno S, Orefice F, Pavesio C, Rao N. (Eds.) Springer Verlag, Heidelberg, Germany, 2011. In: Krachmer JH, Mannis MJ, Holland EJ, Eds. Cornea, 3rd ed., St. Louis, CV Mosby, 2011. Clinical Characteristics of a large Cohort of Patients With Scleritis and Episcleritis Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Ophthalmology, 119: 43-50, 2012. Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease Lemp MA, Bron AJ, Baudoin C, Del Casillo B, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Amer. J Ophthalmology, 2011; 151:792-798. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommitte on Management and Treatment of Meibomian Gland Dysfunction Geerling G, Tauber J, Baudoin C, Goto E, Matsumoto Y, O’Brien T, Rolando M, Tsubota K, Nichols KK. Investigative Ophthalmology & Visual Science, Special Edition 2011, Vol. 52, No. 4; 2050-2064. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Ophthalmology, 119: 51-58, 2012. Is There a Difference Between the Various Corticosteroid Preparations? Tauber J In: Foster CS ed., Curbside Consultation in Uveitis: 49 Clinical Questions, Thoroughfare NJ, Slack, 2012: 41-44.
Bibliography

Parasitic Keratitis and Conjunctivitis.
Tauber J, Anzaar F. In: Jaypee Brothers. Ed. by Sainz de la Maza M, Tauber J, Foster CS. New York, Springer-Verlag, 2012. pp. 1-307. Scleritis Associated with Inflammatory Bowel Disease Sainz de la Maza M, Molina N, Alonso Gonzalez-Gonzalez L, Doctor PP, Tauber J, Foster CS, Investigative Ophthalmology Visual Science, in press. Clinical features and presentation of posterior scleritis: a report of 31 cases Gonzalez-Gonzalez LA, Molina-Prat N, Priyanka Doctor P, Tauber J, Sainz de la Maza M, Foster CS, Ocular Immunolgy and Inflammation 2013, in press. Recent Participation in Multicenter Research Studies
1990-1992
Cyclosporine-High Risk Corneal Transplantation Study 1990-1996
1990-1995
Fibronectin Eyedrops in the Treatment of Nonhealing Corneal Ulcers 1992-1993
Efficacy of Carbomer Gel Versus Hypotears in Dry Eye Patients 1992-1994
Efficacy and Safety of Rimexolone Ophthalmic Suspension Versus Pred Forte 1% for the Treatment of Uveitis 1992-1993
Efficacy and Safety Evaluation of Lodoxamide 0.1% Ophthalmic Solution Versus Placebo in Vernal Keratoconjunctivitis 1992-1994
Adjunctive Therapy with GalardinTM Matrix Metalloproteinase Inhibitor in Patients with Corneal Ulcers Caused by Infection 1992-1994
Adjunctive Therapy with GalardinTM Matrix Metalloproteinase Inhibitor in Patients with Corneal Ulcers Caused by Rheumatoid Arthritis 1992-1993
A Clinical Study Evaluating the Ocular Safety, Comfort and Efficacy Of Cellufresh Compared with Celluvisc, Hypotears P.F. and Tears Naturale II in Subjects with Dry Eye Syndrome 1992-1993
A Prospective, Randomized, Double-Masked, Parallel Group, Two Week, Multicenter Comparison Trial of the Ocular Efficacy and Safety Of Voltaren Ophthalmic 0.1% Solution With That Of Acular 0.5% Ophthalmic Solution In Patients With Acute Seasonal Allergic Conjunctivitis 1993-1994
Safety and Efficacy of Lotoprednol Etabonate in Acute Anterior Uveitis 1994-1995
A Clinical Study Comparing the Ocular Safety and Efficacy Of Acular With Livostin And Vehicle In Subjects With Seasonal Allergic Conjunctivitis 1994-1996
A Double-Masked, Double-Dummy, Randomized, Acyclovir Controlled, Parallel Group Study To Compare The Efficacy And Safety Of Famciclovir With Acyclovir In The Treatment Of Patients With Ophthalmic Zoster 1995-1996
A Dose-Ranging Study Evaluating the Safety, Tolerability, and Efficacy of Cyclosporine and Vehicle Ophthalmic Emulsions in The Treatment of Moderate to Severe Keratoconjunctivitis Sicca 1996-1996
Comparison of Lotprednol Etabonate in Acute Anterior Uveitis and Placebo in the Treatment of Inflammation Following Cataract Surgery With Intraocular Lens Implantation 1996-1997
Multicenter Comparison of the Comfort and Efficacy of Genteal Ophthalmic Lubricant Solution Versus Refresh Plus Ophthalmic Lubricant Solution in the Treatment of Patients With Dry Eye Syndrome 1997-1998
A randomized double-masked (investigator), active-controlled, parallel Evaluation of the safety and efficacy of Cidofovir topical ophthalmic solution in the treatment of viral epidemic keratoconjunctivitis 1997-1998
A Randomized, Single-Masked (Investigator), Active-Controlled, Parallel Evaluation Of The Safety And Efficacy Of Cidofovir Topical Ophthalmic Solution In The Treatment Of Herpes Epithelial Keratitis 1997-1998
A Safety And Efficacy Assessment Of Hyaluronidase Solution Injected Into The Vitreous Body Of The Eye To Hasten The Clearing Of Blood From The Vitreous Recent Participation in Multicenter Research Studies

1997-1998
A Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study of the Safety and Efficacy of Cyclosporine 0.05% And 0.1% Ophthalmic Emulsions Used Twice Daily for Up To One Year In Patients With Moderate to Severe Keratoconjunctivitis Sicca 1998-1999
A Six Month, Multicenter, Triple-masked, Placebo-Controlled Adjunctive Therapy Study of the Safety and Efficacy of AL-6221 0.0015% and AL-6221 0.004% Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension Maintained on Timoptic 0.5% 1998-2000
A Phase III Study of MDX-RA Compared With Placebo Administered in Patients Undergoing Extracapsular Extraction with Phacoemulsification 1998-1999
A Multicenter, Open-Label, Phase 2 Study Extension Evaluating the Safety of Cyclosporine 0.1% Ophthalmic Emulsion Used Twice Daily for Up to One Additional Year in Patients With Moderate to Severe Keratoconjunctivitis Sicca 1998-2000
A Multicenter, Open-Label, Phase 3 Study Extension Evaluating the Safety of Cyclosporine 0.1% Ophthalmic Emulsion Used Twice Daily for One Additional Year in Patients With Moderate to Severe Keratoconjunctivitis Sicca Previously Dosed for 6 to 12 Months with 1998-2001
Safety and Efficacy Study of Vitrase (Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage 1998-1999
RUF366 A Pilot Study of Zenarestat 0.3% (RUF366) For the Treatment of Corneal Epitheliopathy Associated With Diabetes Mellitus 1998-1999
Genteal-Gel Ophthalmic Lubricant in the Treatment of Patients with Moderate to Severe Dry Eye Syndrome 1999-Present
A 48 Month, Multicenter, Randomized, Double-Masked, Placebo- Controlled, Clinical Study To Evaluate The Effectiveness And Safety Of Oral Memantine In Daily Doses Of 20mg And 10mg In Patients With Chronic Open Angle Glaucoma At Risk For Glaucomatous Progression 2000-2001
Cyclosporine 0.05% Ophthalmic Emulsion vs Tears Naturale Free Used Twice Daily In Increasing Daily Lens Comfort and Wear Time Joseph Tauber, M.D., Primary Investigator 2000-2001
Memantine Oral Doses of 20mg and 10mg In Patients with Chronic Open-Angle Glaucoma At Risk for Glaucomatous Progression 2001-2002
Inspire 365 Ophthalmic Solution vs Placebo In Patients with Moderate 2001-2002
A Multicenter Evaluation of Strategies to Optimize the Tolerability of 2001-2004
Randomized, 5 Year Postmarketing Safety Study of Xalatan Compared to “Usual Care” in Patients with Open-Angle Glaucoma or Ocular 2001-2004
A Three Month Clinical Study Comparing the Efficacy and Tolerability of Alphagan and Xalatan in subjects with Chronic Open-Angle Glaucoma or Chronic Ocular Hypertension Presently on Topical Beta Blockers Recent Participation in Multicenter Research Studies

2001-2004
A Four-Month, Randomized, Double-Masked, Parallel Group, Two-Arm Study Comparing the Safety and Efficacy of Alphagan 0.2%/Xalatan 0.005% Combination Therapy and Cosopt Combination Therapy for the Reduction Of Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension 2001-2003
A Multi-Center, Parallel, Randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Evaluate the Safety, Tolerability and Efficacy of Testosterone 0.01%, 0.1%, and 0.3% Ophthalmic Solutions Administered Twice Daily for 16 weeks in Patients with Keratoconjunctivitis Sicca 2001-2003
A Multi-Center, Double- Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects with Dry Eye Disease. 2001-2002
A Prospective, Randomized, Parallel-group, Multi-center, Double-masked Trial Comparing the Efficacy and Safety of 1.5% Levofloxacin Ophthalmic Solution with 03.% Ofloxacin Ophthalmic Solution for Treating Bacterial Keratitis. 2004-2005
A 21 Day, Pilot, Multicenter, Investigator-masked Randomized Parallel Comparison of the Safety and Efficacy of Gatifloxacin 0.3% Ophthalmic Solution Compared with Ciprofloxacin 0.3% Ofloxacin Ophthalmic Solution in Patients with Acute Bacterial Corneal Ulcers. 2004-2005
A Multi-Center, Parallel Group, Double- Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafasol Tetrasodium Ophthalmic Solution, 2% in Subjects with Dry Eye Disease. 2004-2005
Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multi-Center, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel Group, 26 Week Study. 2005-2007
A 24 week randomized, double-blind, multicenter, parallel-group, placebo-controlled evaluation of the safety and efficacy of 0.3% and 1% pimecrolimus ophthalmic suspensions used twice daily in patients with moderate to sever keratoconjunctivitis sicca., 2005-2006
Optimization of Clinical Testing in Patients with Dry Eye. 2005-2007
A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 compared to Vigamox™ in the Treatment of Bacterial Conjunctivitis. 2005-2007
Randomized, Double-Masked Study of Rimexolone 0.2% and Vehicle in Treatment of Dry 2006-2009
A Double-Masked, Placebo-Controlled, Parallel Group, Multi-center, Dose-ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight Threatening, Non-Infectious Intermediate-, Anterior and Intermediate-, Posterior- or Pan- 2006-2009
A Double-Masked, Placebo-Controlled, Parallel Group, Multi-center, Dose-ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Clinically Quiescent Sight Threatening, Non-Infectious Intermediate-, Anterior and Intermediate-, Posterior- or Pan- Uveitis 2006-2009
A Double-Masked, Placebo-Controlled, Parallel Group, Multi-center, Dose-ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight Threatening, Non-Infectious Anterior Uveitis 2007-2009
A Multi-center, Placebo-Controlled, Randomized, Parallel-Group Dose-Ranging Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure Following Penetrating Keratoplasty with LX201 Implantation In Subjects Who Are At Increased Immunological Risk 2007-2009
A Multi-center, Placebo-Controlled, Randomized, Parallel-Group Dose-Ranging Study to Assess the Efficacy and Safety of LX201 Implantation for the Prevention of Corneal Allograft Rejection Episodes or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty 2007-2008
A Phase III Study of the Efficacy and Safety of Cyclosporine Ophthalmic Solution, 0/1% (STA-603) Compared to Vehicle in Subjects with Moderate to Severe Dry Eye Syndrome 2007-2008
A Phase 2b Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis 2007-2008
CR-1485CJ Evaluation of Multifocal Soft Contact Lens Designs 2008-2009
A Multi-Center, Open-Label, Randomized, Pilot Study of the Safety and Efficacy of Azasite Ophthalmic Solution 1% in Combination With Mechanical Therapy vs. Mechanical Therapy Alone in Subjects with Blepharitis 2008-2009
Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients with Facial Rosacea 2008-2009
A Phase II Randomized, Masked, Parallel-Group Study of Safety and Preliminary Efficacy of the Latanoprost Punctum Plug Delivery System in Subjects with Primary Open 2008-2009
An Open-Label Proof-Of-Concept Study To Assess The Effects of Two AIN457 Doses (on Day 1 and Day 22) In Patients With Noninfectious Uveitis 2009-2009
A Multicenter, Parallel Group, Double-masked, Randomized, Placebo-controlled Study of The Effects of Diquafasol tetrasodium Ophthalmic Solution, 2% In Subjects With Dry Eye Disease and a Central Corneal Staining Score of 3 (NEI Scale) 2009-2009
An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA 2009-2012
A Device Evaluation Study to Assess the Physical and Clinical Performance of Prototype 2009-2009
An Open-Label, Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS in Subjects With Ocular Hypertension (OH) or Open-Angle 2009-2009
A Phase I/II Prospective, Randomized, Double Masked, Vehicle And Comparator Controlled, Dose Ranging Study Of Cp-690,550 In Subjects With Dry Eye Disease 2009-2009
A Multi-Center, Open Label Randomized Pilot Study of the Safety and Efficacy of Azasite Ophthalmic Solution, 1% in Combination with Mechanical Therapy versus Mechanical Therapy Alone in Subjects with Blepharitis 2009-2010
A Clinical Safety and Efficacy Evaluation of Zylet® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) compared to Lotemax® (loteprednol etabonate ophthalmic suspension 0.5%), Tobramycin Ophthalmic Solution USP, 0.3%, and the Vehicle of Zylet® for the Treatment of Blepharoconjunctivitis in Pediatric 2009-2010
A Multi-Center, Double Masked, Placebo-Controlled, Parallel-Group, Randomized Study of the Safety and Efficacy of Azithromycin Ophthalmic Solution, 1% versus Placebo for Four Weeks in Subjects with Dry Eye Disease 2010-2011
A Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Multicenter, Exploratory Study Assessing Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome 2011-2011
A Randomized, Multi-Center, Double-Masked, Vehicle- Controlled, Parallel-Group, Safety and Efficacy Study of Azithromycin Ophthalmic Solution, 1% versus Vehicle for Four Weeks in Subjects with Blepharitis 2011-2013
A Prospective, Multi-Center, Randomized, Double-Masked, Positive-Controlled Phase 3 Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution Compared to Prednisolone Acetate (1%) in Patients with Non-Infectious Anterior Segment Uveitis 2012-2013
A Randomized, Double-Masked, Parallel –Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-502 (1.0% Azithromycin and 0.1% Dexamethasone) Compared to Azasite alone, Dexamethasone 0.1% alone and Vehicle in the Treatment of Patients with Non-Bacterial Blepharitis 2012-2013
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of 2% Rabamipide versus placebo in the treatment of Dry Eyes. 2012-2013
A Randomized, Double-masked, Placebo-controlled, Dose-Ranging Study of EBI-005 Ophthalmic Solution versus Placebo in subjects with Dry Eye Syndrome. 2013-2013
A Phase 3, Multicenter, Randomized, Double Masked and Placebo Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects with Dry Eye Currently Using Artificial Tears (OPUS-2) 2013-2013
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of GevokizumAb in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis 2013-2013
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of GevokizumAb in the Treatment of Subjects with Non-infectious Intermediate, Posterior, or Pan- uveitis Currently Controlled with Systemic Treatment 2013-Present
Ophthalmic AGN195263 for the Treatment of Meibomian Gland Dysfunction

Source: http://www.taubereye.com/wp-content/uploads/2014/01/1919e7ebd516f4efe1e605613e38cbea.pdf